Under pressure from the FDA, Abbott Laboratories has pulled the weight loss drug Meridia (sibutramine) from the market because of the increased incidence of strokes and heart attacks.
InsideSurgery Medical Information Blog
Details of surgical procedures, pathophysiology, signs and symptoms, and treatment of medical diseases,medical and surgical eponyms, and surgeons and surgery in the news
Under pressure from the FDA, Abbott Laboratories has pulled the weight loss drug Meridia (sibutramine) from the market because of the increased incidence of strokes and heart attacks.
Leave a Reply